GenSight Biologics Releases Interim Financial Report for First Half of 2024 and Provides Business Updates

GenSight Biologics Reports Interim Financial Results for First Half of 2024 Overview GenSight Biologics, a biopharma company focused on developing gene therapies for retinal neurodegenerative diseases and central nervous system disorders, recently announced its interim financial results for the first half of 2024. The company’s 2024 half-year financial statements underwent a limited review by its…

Read More

Unlocking the Power of Access: A Guide to Maximizing Your Online Presence

Levi & Korsinsky, LLP Investigates Acquisition of P3 Health Partners, Inc. Investigation Into Fairness of Acquisition The law firm Levi & Korsinsky, LLP has recently announced that it is investigating the acquisition of P3 Health Partners, Inc. (NASDAQ:PIII). The investigation focuses on whether the acquisition of the company, known as Foresight Acquisition Corp. (FORE) at…

Read More

Attention Investors: Don’t Miss Out on the Deadline for the GitLab Inc. Class Action Lawsuit – A Reminder from Glancy Prongay Murray LLP!

Don’t Miss the Deadline! Get Your Lead Plaintiff Motion in for GitLab Inc. Class Action Lawsuit What’s the Deal with GitLab Inc.? So, you might have heard about this whole GitLab Inc. situation and the class action lawsuit that’s been filed. If not, let me bring you up to speed! GitLab Inc. is a company…

Read More

EuroDry to Participate in Noble Capital Markets Basic Industries Emerging Growth Virtual Equity Conference

EuroDry Ltd. CFO to Present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference ATHENS, Greece, Sept. 23, 2024 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today that its CFO, Dr. Tasos Aslidis, will present…

Read More

Laughing All the Way to the Bank: A Quirky Look at Our Own Share Transaction – Blog Edition!

Transaction in Own Shares 23 September, 2024 Shell plc (the ‘Company’) announces share purchases On 23 September 2024, Shell plc announced that it purchased a significant number of its own shares for cancellation. The aggregated information on shares purchased on different trading venues is as follows: London Stock Exchange (LSE) Date of purchase: 23/09/2024 Number…

Read More

Calling All Investors: Don’t Miss Out on This Shareholder Shindig with Faruqi & Faruqi LLP!

Welcome to the Faruqi & Faruqi Blog! Investors Beware: STMicroelectronics Alert! Hey there, savvy investors! If you’ve been keeping an eye on STMicroelectronics, you may want to pay extra close attention to this latest update. Faruqi & Faruqi, LLP Securities Litigation Partner, James (Josh) Wilson, is on the case and ready to help investors who…

Read More